The role of biologics in treatment of ANCA-associated vasculitis. - Wikidata - awgldk - TriplyDB

The role of biologics in treatment of ANCA-associated vasculitis.

The role of biologics in treatment of ANCA-associated vasculitis.

http://www.wikidata.org/entity/Q37950904

about

ANCA Associated Mononeuritis Multiplex with Overlap in Vasculitic Syndromes.Unusual cause of flare in antineutrophil cytoplasmic antibody-associated vasculitis.

P2860

Q37663661-7D8E9656-BA89-4728-9263-324C2A83A7E3 Q54886115-E85BC1ED-1A24-4AAC-8371-E67EED6C9D77

P2860

The role of biologics in treatment of ANCA-associated vasculitis.

http://www.wikidata.org/entity/Q37950904

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The role of biologics in treatment of ANCA-associated vasculitis.

@en

The role of biologics in treatment of ANCA-associated vasculitis.

@nl

type

label

The role of biologics in treatment of ANCA-associated vasculitis.

@en

The role of biologics in treatment of ANCA-associated vasculitis.

@nl

prefLabel

The role of biologics in treatment of ANCA-associated vasculitis.

@en

The role of biologics in treatment of ANCA-associated vasculitis.

@nl

P1433

Q37950904-B8A8BD36-AF8F-4BB4-B4DD-8F87BBAC7754

P1476

Q37950904-CAB0F8D5-F595-4F35-BA6B-94533F946283

P2093

Q37950904-72D62601-2A92-4526-8FA3-DA8619717B01

Q37950904-F47C922B-0AD8-4CE1-97A2-68557C9F4932

P2860

Q37950904-00E9BCE3-974F-4652-A842-B0EED5ED6358

Q37950904-02B44467-FAE7-4A3D-AF55-1F2528D4526E

Q37950904-06055C39-537E-4DAF-8004-1C1A60C53443

Q37950904-0A0585B2-B3B9-4442-B611-D55C95D095AF

Q37950904-23A8A38B-F4A4-46AE-9ABF-352645580573

Q37950904-3DA27722-45C7-44E6-901C-49EB8ECB66E1

Q37950904-426090E5-CBA4-487B-91D0-25365063C8EB

Q37950904-51A4618F-08A7-43B7-A3C5-CB2FF6A4E470

Q37950904-5533937D-38A7-492B-9111-95D174AD6C21

Q37950904-56A8E53C-C1D2-4DAF-8E82-EBC596B1A915

P304

Q37950904-48A7C2FC-55BF-4A07-AAC4-2BDDE5210BD9

P31

Q37950904-A9B1AE8E-EC15-4B34-8C9A-BE04172816E4

P356

Q37950904-7357ADC2-A69A-4FCD-A6AE-C9AB784F49F6

P433

Q37950904-01FACECE-9B6C-4486-BC3B-FB6204279B93

P478

Q37950904-26E1006E-4374-4CD1-83B5-AA8101D6DE5B

P577

Q37950904-C2E3DD04-7F78-40FB-99B5-4FA2C3C498D3

P698

Q37950904-7BD06B9F-E493-4CBE-95AF-6606925DEE36

P356

S10165-011-0548-Y

P1433

Modern Rheumatology

P1476

The role of biologics in treatment of ANCA-associated vasculitis.

@en

P2093

Chethana Dharmapalaiah

http://www.w3.org/2001/XMLSchema#string

Richard A Watts

http://www.w3.org/2001/XMLSchema#string

P2860

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis

Pathogenesis of ANCA-associated systemic vasculitis.

IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

EULAR recommendations for the management of primary small and medium vessel vasculitis.

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

P304

319-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/S10165-011-0548-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22038317

http://www.w3.org/2001/XMLSchema#string